Kevala is a technology company.
Kevala has raised $37.0M across 3 funding rounds.
Kevala has raised $37.0M in total across 3 funding rounds.
Kevala is a healthcare technology company that builds an AI-powered workforce management and scheduling platform designed to optimize staffing for healthcare organizations, such as senior living communities and hospital systems.[2][3][5] It serves overburdened healthcare providers facing labor shortages, burnout, and compliance challenges by automating shift filling, credential tracking, call-out management, and schedule balancing in real time, ultimately reducing costs and improving care delivery.[2][3][5] The platform addresses pain points like outdated tools and manual processes, enabling facilities to build and schedule credentialed, on-demand workforces with minimal effort, with recent momentum including a next-generation scheduling solution release and partnerships like SnapNurse.[3][5]
Kevala was co-founded in 2020 by Todd Owens (CEO), Patrick Lawler, and Noah Kusz amid the COVID-19 crisis, which exposed critical flaws in healthcare workforce management—such as schedules on walls, unusable software, shrinking teams, and soaring costs.[2] The founders, recognizing that hospitals struggled not just with staff shortages but with ineffective tools, aimed to create a healthcare-specific platform rather than generic solutions from other industries.[2] Early traction built on this "call to action," evolving into a comprehensive AI-driven system for staffing optimization, with headquarters in Seattle and a focus on the fast-growing U.S. healthcare employment sector.[2][3]
(Note: Distinct from unrelated energy analytics firms sharing the name, Kevala's healthcare focus stands out via AI precision and sector-specific compliance.[1][4])
Kevala rides the healthcare labor shortage wave, a public health crisis amplified by post-COVID burnout, an aging population, and the sector's status as the U.S.'s largest, fastest-growing employer.[2][3] Timing is ideal amid rising AI adoption in healthcare for efficiency, with market forces like regulatory demands and cost pressures favoring automated platforms over legacy systems.[5] It influences the ecosystem by enabling tech-enabled staffing (e.g., via SnapNurse integration) and advancing global workforce optimization, helping organizations scale care without proportional headcount growth.[3]
Kevala is poised to expand its AI platform amid deepening healthcare staffing crises, potentially dominating with features like predictive acuity-based scheduling and deeper integrations. Trends like AI regulation, telehealth growth, and value-based care will shape its path, amplifying demand for compliance-safe automation. Its influence may evolve from niche optimizer to ecosystem leader, powering resilient care delivery as labor dynamics intensify—echoing its origins as a crisis-born solution now scaling for enduring impact.[2][3][5]
Kevala has raised $37.0M in total across 3 funding rounds.
Kevala's investors include Bain Capital, Bowery Capital, Costanoa Ventures, DNA Capital, Elevate Ventures, Foundation Capital, Foundry Group, High Alpha, March Capital, Matchstick Ventures, Maven Ventures, TM3 Capital.
Kevala has raised $37.0M across 3 funding rounds. Most recently, it raised $12.0M Series A in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2022 | $12.0M Series A | Bain Capital, Bowery Capital, Costanoa Ventures, DNA Capital, Elevate Ventures, Foundation Capital, Foundry Group, High Alpha, March Capital, Matchstick Ventures, Maven Ventures, TM3 Capital, Vulcan Capital, Y Combinator, Tim Seears, Trevor Wright | |
| Aug 1, 2021 | $21.0M Series A | Costanoa Ventures, High Alpha, Powerhouse Ventures | |
| Oct 1, 2020 | $4.0M Seed | Bowery Capital, DNA Capital, Elevate Ventures, Foundation Capital, Foundry Group, High Alpha, Matchstick Ventures, Maven Ventures, TM3 Capital, Y Combinator, Tim Seears |